PVigi
Pharmacovigilance services by country

Global Pharmacovigilance Coverage & Local Regulatory Expertise

One coordinated partnership for local pharmacovigilance requirements across 25+ markets. PVigi provides local pharmacovigilance, QPPV and local PV contact services in 25+ countries across Türkiye, Europe, the Middle East, Africa, the CIS and Central Asia, alongside EU-wide QPPV services.

Local Expertise

Country-specific knowledge of each authority, language and requirement.

Central Coordination

One coordinated model: one contract, one process and one point of contact.

Quality Oversight

Consistent processes and shared SOPs, so every market follows the same standard.

7Europe4Middle East5Africa12CIS & C. Asia

One hub, five regions

Our team in Türkiye coordinates local PV contacts and literature reviewers in every country below, so you have one contract, one process and one point of contact.

Türkiye (Turkey) & Europe

In Türkiye (Turkey), our home market, we act as local QPPV (Farmakovijilans Yetkilisi) registered with TİTCK, submit ICSRs to TÜFAM and screen Turkish literature weekly. Elsewhere we provide local contact persons for pharmacovigilance (LPPV) and national literature screening in EU member states Greece, Bulgaria, Lithuania, Latvia and Estonia, working with your EU QPPV under EU GVP, and local PV representation in Bosnia and Herzegovina.

Pharmacovigilance in Türkiye (Turkey)

Local QPPV registered with TİTCK, ICSR reporting to TÜFAM and weekly Turkish literature screening.

Pharmacovigilance in Greece

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Greece.

Pharmacovigilance in Bulgaria

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Bulgaria.

Pharmacovigilance in Bosnia and Herzegovina

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Bosnia and Herzegovina.

Pharmacovigilance in Lithuania

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Lithuania.

Pharmacovigilance in Latvia

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Latvia.

Pharmacovigilance in Estonia

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Estonia.

Middle East

Local qualified persons and safety officers in Saudi Arabia, the United Arab Emirates and Oman under GCC and SFDA pharmacovigilance requirements, and local PV support in Israel, including Arabic and Hebrew literature screening.

Pharmacovigilance in Israel

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Israel.

Pharmacovigilance in Saudi Arabia

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Saudi Arabia.

Pharmacovigilance in United Arab Emirates

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in United Arab Emirates.

Pharmacovigilance in Oman

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Oman.

Africa

Local PV contacts in Egypt, Tunisia, Algeria, Morocco and Libya: adverse event intake, reporting to national authorities, Arabic and French literature screening and regulatory intelligence.

Pharmacovigilance in Egypt

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Egypt.

Pharmacovigilance in Tunisia

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Tunisia.

Pharmacovigilance in Algeria

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Algeria.

Pharmacovigilance in Morocco

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Morocco.

Pharmacovigilance in Libya

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Libya.

CIS, Caucasus & Central Asia

Local PV responsible persons and Russian-language literature screening across the region, with Eurasian Economic Union (EAEU) GVP compliance in Russia, Belarus, Kazakhstan, Armenia and Kyrgyzstan, and national requirements in Ukraine, Moldova, Azerbaijan, Uzbekistan, Tajikistan, Turkmenistan and Mongolia.

Pharmacovigilance in Russia

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Russia.

Pharmacovigilance in Ukraine

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Ukraine.

Pharmacovigilance in Belarus

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Belarus.

Pharmacovigilance in Moldova

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Moldova.

Pharmacovigilance in Azerbaijan

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Azerbaijan.

Pharmacovigilance in Armenia

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Armenia.

Pharmacovigilance in Kazakhstan

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Kazakhstan.

Pharmacovigilance in Uzbekistan

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Uzbekistan.

Pharmacovigilance in Kyrgyzstan

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Kyrgyzstan.

Pharmacovigilance in Tajikistan

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Tajikistan.

Pharmacovigilance in Turkmenistan

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Turkmenistan.

Pharmacovigilance in Mongolia

Local PV contact, adverse event reporting, literature screening and regulatory intelligence in Mongolia.